[13] |
Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma[J]. Cancer cell, 2002, 2(5):367-376.
|
[14] |
Strauss BL, Bratthauer GL, Tavassoli FA. STAT 5a expression in the breast is maintained in secretory carcinoma,in contrast to other histologic types [J]. Hum Pathol, 2006, 37 (5):586-592.
|
[15] |
Laé M, Fréneaux P, Sastre-Garau X, et al. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basallike carcinoma spectrum [J]. Mod Pathol, 2009, 22(2):291-298.
|
[16] |
Osako T, Takeuchi K, Horii R, et al. Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis[J]. Histopathology, 2013, 63 (4):509-519.
|
[17] |
Arce C, Cortes-Padilla D, Huntsman DG, et al. Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature[J].World J Surg Oncol,2005,3:35.
|
[18] |
Richard G, Hawk JC 3rd, Baker AS Jr, et al. Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature[J]. J Surg Oncol,1990,44(4):238-244.
|
[19] |
Amott DH, Masters R, Moore S. Secretory carcinoma of the breast[J]. Breast J,2006,12(2):183.
|
[20] |
Mun SH, Ko EY, Han BK, et al. Secretory carcinoma of the breast: sonographic features. J Ultrasound Med,2008,27(6):947-954.
|
[21] |
Maitra A, Tavassoli FA, Albores-Saavedra J, et al. Molecular abnormalities associated with secretory carcinomas of the breast]J]. Hum Pathol,1999,30(12):1435-1440.
|
[22] |
Vieni S, Cabibi D, Cipolla C, et al. Secretory breast carcinoma with metastatic sentinel lymph node[J]. World J Surg Oncol,2006,4:88.
|
[1] |
McDivitt RW, Stewart FW. Breast carcinoma in children [J].JAMA,1966,195(5):388-390.
|
[2] |
Ozguroglu M, Tascilar K, Ilvan S, et al. Secretory carcinoma of the breast. Case report and review of the literature[J].Oncology,2005,68(2/3):263-268.
|
[3] |
皋岚湘, 丁华野. 新版WHO 乳腺浸润性癌组织学类型的特点概述[J].中华病理学杂志,2004,33(4):382-384.
|
[4] |
齐晓伟, 姜军. 2012 年第4 版《WHO 乳腺肿瘤组织学分类》介绍[J/CD]. 中华乳腺病杂志:电子版, 2012, 6(5):586-591.
|
[5] |
付丽, 刘彤华, 傅西林. 乳腺疾病病理彩色图谱[M]. 北京:人民卫生出版社,2013:221-224.
|
[6] |
Cadoo KA, McArdle O, O'Shea AM, et al. Management of unusual histological types of breast cancer[J]. Oncologist,2012,17(9):1135-1145.
|
[7] |
郎荣刚,牛昀,范宇. 分泌型乳腺癌的临床病理特征[J].临床与实验病理学杂志,2001,17(1):1-4.
|
[8] |
Li D, Xiao X, Yang W, et al. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature[J]. Mod Pathol,2012,25(4):567-575.
|
[9] |
Horowitz DP, Sharma CS, Connolly E, et al. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database[J]. Breast,2012,21(3):350-353.
|
[10] |
Akhtar M, Robinson C, Ali MA, et al. Secretory carcinoma of the breast in adults. Light and electron microscopic study of three cases with review of the literature[J]. Cancer, 1983,51(12):2245-2254.
|
[11] |
Tavassoli FA, Norris HJ. Secretory carcinoma of the breast[J]. Cancer,1980,45(9):2404-2413.
|
[12] |
Choi J, Kim D, Koo JS. Secretory carcinoma of breast demonstrates nuclear or cytoplasmic expression in p63 immunohistochemistry[J]. Int J Surg Pathol, 2012, 20(4):367-372.
|